Statement Of Cash Flows [Abstract]
| Concept |
2023-01-01 to 2023-12-31 |
2022-01-01 to 2022-12-31 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Adjustments for finance income (cost) |
97,000,000
EUR
|
65,000,000
EUR
|
| Cash flows from (used in) operations before changes in working capital |
600,000,000
EUR
|
789,000,000
EUR
|
| Adjustments for decrease (increase) in trade and other receivables |
823,000,000
EUR
|
654,000,000
EUR
|
| Adjustments for increase (decrease) in trade and other payables |
887,000,000
EUR
|
827,000,000
EUR
|
| Adjustments for increase (decrease) in employee benefit liabilities |
7,000,000
EUR
|
10,000,000
EUR
|
| Adjustments for amortisation expense |
96,000,000
EUR
|
104,000,000
EUR
|
| Adjustments for depreciation expense |
348,000,000
EUR
|
351,000,000
EUR
|
| Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, trade and other receivables |
13,000,000
EUR
|
34,000,000
EUR
|
| Adjustments for gains (losses) on change in fair value less costs to sell, biological assets |
11,000,000
EUR
|
17,000,000
EUR
|
| Adjustments for undistributed profits of investments accounted for using equity method |
52,000,000
EUR
|
43,000,000
EUR
|
| Income taxes paid, classified as operating activities |
42,000,000
EUR
|
1,000,000
EUR
|
| Cash flows from (used in) investing activities [abstract] | ||
| Dividends received from investments accounted for using equity method, classified as investing activities |
21,000,000
EUR
|
22,000,000
EUR
|
| Cash flows from (used in) financing activities [abstract] | ||
| Payments for debt issue costs |
1,000,000
EUR
|
1,000,000
EUR
|